Classification of menstrual bleeding disorders

Reviews in Endocrine and Metabolic Disorders

Volumn 13, Issue 4, 2012, Pages 225-234

  Munro, Malcolm G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abnormal uterine bleeding; Classification system; FIGO; Heavy menstrual bleeding; Leiomyomas; Menstrual disorders

Indexed keywords

ADENOMYOSIS; ARTICLE; BLOOD CLOTTING DISORDER; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOMETRIAL DISEASE; FIGO CLASSIFICATION SYSTEM; GYNECOLOGIC CANCER; HUMAN; HYPERPLASIA; IATROGENIC DISEASE; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL STUDENT; MENSTRUAL BLEEDING DISORDER; MENSTRUATION DISORDER; METRORRHAGIA; NOMENCLATURE; OVARY INSUFFICIENCY; PATIENT ASSESSMENT; PRECANCER; RESIDENT; UTERUS MYOMA;

BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; INTERNATIONAL AGENCIES; MENSTRUATION DISTURBANCES; OVARIAN DISEASES; PRACTICE GUIDELINES AS TOPIC; UTERINE DISEASES; UTERINE HEMORRHAGE; VOCABULARY, CONTROLLED; VOLUNTARY HEALTH AGENCIES;

EID: 84874654065     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-012-9220-x     Document Type: Article

References (53)

1. Gath D, Osborn M, Bungay G, Iles S, Day A, Bond A, et al. Psychiatric disorder and gynaecological symptoms in middle aged women: A community survey. Br Med J (Clin Res Ed). 1987;294(6566):213-8. (Pubitemid 17231391)
2. Peto V, Coulter A, Bond A. Factors affecting general practitioners' recruitment of patients into a prospective study. Fam Pract. 1993;10(2):207-11. (Pubitemid 23210386)
3. Heavy menstrual bleeding. In N. I. f. H. a. C. Excellence (Ed.), (Vol. 44). United Kingdom: National Institute for Health and Clinical Excellence. 2007.
4. Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol. 1995;86(5):764-9. doi: 10.1016/0029-7844(95) 00252-M.
5. Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol. 2003;188(2):343-8. (Pubitemid 36249968)
6. Frick, K. D.; Clark, M. A.; Steinwachs, D. M.; Langenberg, P.; Stovall, D.; Munro, M. G.; et al. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. [Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S.]. Women's health issues: official publication of the Jacobs Institute of Women's Health. 2009;19(1), 70-78, doi: 10.1016/j.whi.2008.07.002.
7. Liu, Z.; Doan, Q. V.; Blumenthal, P.; & Dubois, R. W. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. [Research Support, Non-U.S. Gov't Review]. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2007;10(3), 183-194, doi: 10.1111/j.1524-4733.2007.00168.x. (Pubitemid 46802276)
8. Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril. 2008;90(6):2269-80. doi: 10.1016/j.fertnstert.2007.10.060.
9. Munro MG, Critchley HO, Broder MS, Fraser IS. The FIGO classification system ("PALM-COEIN") for causes of abnormal uterine bleeding in Non-gravid women in the reproductive years, including guidelines for clinical investigation. Int J Gynaecol Obstet. 2011;113(1):3-13.
10. Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007;22(3):635-43. doi: 10.1093/humrep/del478.
11. Fraser IS, Critchley HO, Munro MG, Broder M. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87(3):466-76. doi: 10.1016/j.fertnstert.2007.01.023. (Pubitemid 46385988)
12. Critchley HO, Munro MG, Broder M, Fraser IS. A five-year international review process concerning terminologies, definitions, and related issues around abnormal uterine bleeding. Seminars in Reproductive Medicine. 2011;29(5):377-82. doi: 10.1055/s-0031-1287661.
13. Munro MG. Abnormal uterine bleeding. Cambridge: Cambridge University Press; 2010.
14. Rosenbaum SP, Fried M, Munro MG. Endometrial hydrothermablation: A comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology. J Minim Invasive Gynecol. 2005;12(2):144-9. doi: 10.1016/j.jmig.2005.01.018. (Pubitemid 40800369)
15. Lukes AS, Kadir RA, Peyvandi F, Kouides PA. Disorders of hemostasis and excessive menstrual bleeding: Prevalence and clinical impact. Fertil Steril. 2005;84(5):1338-44. doi: 10.1016/j.fertnstert.2005.04.061. (Pubitemid 41571879)
16. Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: Appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345-51. doi: 10.1016/j.fertnstert.2005.05.035. (Pubitemid 41571880)
17. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril. 2005;84(5):1352-9. doi: 10.1016/j.fertnstert.2005.04.062. (Pubitemid 41571881)
18. Fraser IS, Bonnar J, Peyvandi F. Requirements for research investigations to clarify the relationships and management of menstrual abnormalities in women with hemostatic disorders [Review]. Fertil Steril. 2005;84(5):1360-5. doi: 10.1016/j.fertnstert.2005.07.1268. (Pubitemid 41571882)
19. Seidenfeld ME, Rickert VI. Impact of anorexia, bulimia and obesity on the gynecologic health of adolescents [Review]. Am Fam Physician. 2001;64(3):445-50. (Pubitemid 32756643)
20. Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension. Obstet Gynecol. 1993;82(5):736-40. (Pubitemid 23312179)
21. Lieng M, Istre O, Sandvik L, Qvigstad E. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: Cross-sectional study. J Minim Invasive Gynecol. 2009;16(4):465-71. doi: 10.1016/j.jmig.2009.04.005.
22. Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA. Endometrial polyps: Prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol. 2000;21(2):180-3. (Pubitemid 30240606)
23. Shushan A, Revel A, Rojansky N. How often are endometrial polyps malignant? Gynecol Obstet Invest. 2004;58(4):212-5. doi: 10.1159/000080189. (Pubitemid 39482659)
24. Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):547-55. doi: 10.1016/j.bpobgyn.2006.01.006. (Pubitemid 44688621)
25. Gordts S, Brosens JJ, Fusi L, Benagiano G, Brosens I. Uterine adenomyosis: A need for uniform terminology and consensus classification. Reprod Biomed Online. 2008;17(2):244-8.
26. Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: Systematic review comparing test accuracy. [Comparative study meta-analysis review]. Acta Obstet Gynecol Scand. 2010;89(11):1374-84. doi: 10.3109/00016349.2010.512061.
27. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: A systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Updat. 2012. doi: 10.1093/humupd/dms006.
28. Dueholm M, Lundorf E, Hansen ES, Sorensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril. 2001;76(3):588-94.
29. Palmer SS, Haynes-Johnson D, Diehl T, Nowak RA. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Investig. 1998;5(4):203-9. (Pubitemid 28359817)
30. Bogusiewicz M, Stryjecka-Zimmer M, Postawski K, Jakimiuk AJ, Rechberger T. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium. Gynecol Endocrinol. 2007;23(9):541-6. doi: 10.1080/09513590701557416. (Pubitemid 47621524)
31. Stewart EA, Nowak RA. Leiomyoma-related bleeding: A classic hypothesis updated for the molecular era. Hum Reprod Update. 1996;2(4):295-306. (Pubitemid 26408110)
32. Sinclair DC, Mastroyannis A, Taylor HS. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-beta3. [Research Support, N.I.H.; Extramural]. J Clin Endocrinol Metab. 2011;96(2):412-21. doi: 10.1210/jc.2010-1450.
33. Norman RJ. Obesity, polycystic ovary syndrome and anovulation-how are they interrelated? [Review]. Curr Opin Obstet Gynecol. 2001;13(3):323-7. (Pubitemid 32673534)
34. Tavassoli FA, Devilee P. World health organization classification of tumors: Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003.
35. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(1):105-43. doi: 10.1016/S0020-7292(06)60031-3. (Pubitemid 44854931)
36. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von willebrand disease in women with menorrhagia: A systematic review. BJOG. 2004;111(7):734-40. doi: 10.1111/j.1471-0528.2004.00176.x. (Pubitemid 38869763)
37. Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynecologists concerning menorrhagia: Perceptions of bleeding disorders as a possible cause. J Womens Health Gend Based Med. 2002;11(1):39-44. doi: 10.1089/152460902753473444. (Pubitemid 34196282)
38. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351(9101):485-9. doi: 10.1016/S0140-6736(97)08248-2. (Pubitemid 28070095)
39. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. [Review]. Hum Reprod Updat. 2003;9(4):359-72. (Pubitemid 36987284)
40. Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Menopause. 2009;16(1):50-9. doi: 10.1097/GME.0b013e31817ee0c2.
41. Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol. 1994;171(1):178-83. (Pubitemid 24254438)
42. Smith SK, Abel MH, Kelly RW, Baird DT. A role for prostacyclin (PGi2) in excessive menstrual bleeding. Lancet. 1981;1(8219):522-4. (Pubitemid 11130724)
43. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol. 1981;88(4):434-42. (Pubitemid 11113117)
44. Abraham SF, Beumont PJ, Fraser IS, Llewellyn-Jones D. Body weight, exercise and menstrual status among ballet dancers in training. Br J Obstet Gynaecol. 1982;89(7):507-10. (Pubitemid 12081124)
45. Warren MP, Perlroth NE. The effects of intense exercise on the female reproductive system. [Review]. J Endocrinol. 2001;170(1):3-11. (Pubitemid 32677561)
46. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12(1 Pt 2):77-126.
47. Snowden R, Christian B. Patterns and perceptions of menstruation, a world health organization international collaborative study. London: Croom Helm; 1983.
48. Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Seminars in Reproductive Medicine. 2011;29(5):383-90. doi: 10.1055/s-0031-1287662.
49. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: A randomized controlled trial. Obstet Gynecol. 2011;117(4):777-87. doi: 10.1097/AOG.0b013e3182118ac3.
50. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest. 1964;16:244-8.
51. Newton JR, Barnard G, Collins W. A rapid method for measuring blood loss using automatic extraction. Contraception. 1977;16:269-82. (Pubitemid 8185987)
52. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002. [Guideline Practice Guideline]. Obstetrics and gynecology, 2002;100(6), 1389-1402.
53. Belsey EM, Pinol AP. Menstrual bleeding patterns in untreated women. Task force on long-acting systemic agents for fertility regulation. Contraception. 1997;55(2):57-65. (Pubitemid 27114527)